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Medical Devices 
  
From Malawi to Middlesex – The case of the Arbutus Drill Cover System as an example 
of the cost saving potential of frugal innovations for the UK NHS 
 
ABSTRACT 
 
Background:  
Musculoskeletal disease is one of the leading clinical and economic burdens of the UK health 
system and the resultant demand for orthopaedic care is only set to increase. One commonly 
used and one of the most expensive hardware in orthopaedic surgery is the surgical drill and 
saw. Given financial constraints, the NHS needs an economic way to address this recurring 
cost. We share evidence of one frugal innovation with potential for contributing to the NHS’ 
efficiency saving target of £22bn by 2020. 
Methods:  
Exploratory case study methodology was used to develop insights and understanding of the 
innovations potential for application in the NHS. Following a global search for potential 
frugal innovations in surgery, the Arbutus Drill Cover System was identified as an innovation 
with potential to deliver significant cost-savings for the NHS in the UK.  
Results:  
The Arbutus Drill Cover System is up to 94% cheaper than a standard surgical drill available 
in the UK. Clinical and laboratory tests show that performance, safety and usability is as 
good as current offerings in High Income Countries (HICs) and significantly better than hand 
drills typically used in LMICs. The innovation meets all regulatory requirements to be a 
medical device in the Europe and North America. 
Conclusions:  
The innovation holds promise in reducing upfront and lifespan costs for core equipment used 
in orthopaedic surgery without loss of effectiveness or safety benchmarks. However, the 
innovation needs to navigate complicated and decentralized procurement processes and 
clinicians and healthcare leaders need to overcome cognitive bias.  
250 words 
 
Keywords: Cost saving, orthopaedic surgery, frugal innovation, reverse innovation, NHS 
improvement. 
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INTRODUCTION 
The primary objective of this paper is to present the Arbutus Drill Cover System, a promising 
medical device with significant potential for cost saving for the NHS. This work also reflects 
on the significant challenges faced by entrepreneurs and innovators as they seek to scale up 
promising ideas in the UK and further afield. 
Traumatic injuries are one of the leading causes of disability and death worldwide, 
accounting for nearly 1 in 10 deaths each year [1]. 90% of injury deaths occur in low- and 
middle income countries (LMICs) [2]. Injuries in the UK result in a substantial population 
burden in terms of disability and premature mortality [3]. Musculoskeletal disease accounts 
for over 25% of surgical interventions within the NHS [4]. One of the critical kits commonly 
used in orthopaedic surgery is the surgical drill and saw. All orthopaedic trauma cases require 
a drill except closed reduction of fractures in children. Against a background of an ageing 
population and rise in non-communicable diseases there will be an ever-increasing demand 
for orthopaedic care. As trauma affects a relatively younger population, it accounts for more 
productive years of work lost than other illness, with an enormous economic and societal 
impact.  
The significant £20-30K cost of current clinical surgical drills has meant that trauma and 
orthopaedic surgeons in LMICs resort to using imprecise and slow hand drills or unsterile 
hardware drills, with serious consequences, including disfigurement, severe infection and loss 
of life [5]. In 2012 the lead author undertook an orthopaedic fellowship at Beit-CURE 
International Hospital in Malawi, where he observed the practice of wrapping a commercially 
available hardware drill with an unsterile crude cover; a common practice across LMICs. At 
the same time, in Uganda a group of biomedical engineering students from the University of 
British Columbia also witnessed the same behaviours and sought to convert this jugaad 
practice into a frugal innovation through a structured innovation and design process [6, 7]. 
Arbutus Medical Inc. was incorporated in 2014 for the purposes of commercializing the 
company offering. 
Through case study development, we sought to understand the conception, development and 
implementation of the Arbutus Drill Cover System for the purposes of assessing 
transferability to the NHS, specifically at the West Middlesex University Hospital. 	
METHODS 
Over a two-year period the Institute of Global Health Innovation (IGHI) has conducted an 
international search for frugal innovations with potential application by healthcare providers 
in high-income countries (i.e. potential for reverse innovation) [8, 9]. In 2015 we conducted a 
global search of hundreds of cost saving innovations including products, processes, and 
policies that addressed all types and domains of healthcare [10, 11]. Key criteria used to 
evaluate frugality included affordability, adaptability, and accessibility. In 2016 we narrowed 
down this search to shortlist those related specifically to surgery with potential for piloting in 
the UK’s NHS. One of the most promising offerings we found in surgery is the Arbutus Drill 
4	
	
Cover System. An exploratory case study methodology was used to collect information about 
the Drill Cover System and the company behind its development via a range of data 
collection techniques comprising observation, interview and documentary analysis, for the 
purpose of developing insights about the applicability of the innovation for the UK NHS. We 
focused more on the technology and its potential for piloting, though we also came to 
understand more about the organization backing this technology as part of assessing 
prospects for piloting and scaling. Researchers (IA/YB) undertook multiple telephone and 
face-to-face interviews with the co-founders of Arbutus Medical to understand the conception 
and development of the Drill Cover System. Concurrently, (MP/IA/YB) analysed documents 
related to the innovation including company presentations; laboratory findings; usability 
feedback; technical instructions and regulatory approval information. Subsequently, 
researchers (MP/YB/AI) undertook an international fieldtrip to Uganda and Kenya, where 
three hospitals were visited, to gain perspectives of the Arbutus Drill Cover System from 
frontline healthcare workers; this included observing the drill in surgeries and at the point of 
assembly and disassembly.  
RESULTS 
How was the innovation conceived? 
In 2013, as part of the University of British Columbia’s Engineers in Scrubs programme, a 
team of biomedical engineering researchers, orthopaedic surgeons, registered nurses, 
reprocessing staff, and health administrators from Canada and Uganda looked at pressing 
clinical needs at Mulago Hospital in Kampala, Uganda. They identified the problems arising 
from inadequate availability of expensive surgical drills and embarked on developing a 
solution. The project ideation and lead target market in East Africa is facilitated by urgency 
of need and lax regulatory enforcement. However, design, engineering, manufacturing, 
quality management system, as well as strategic and operational control are based in Canada.  
What are the key features?  
The Arbutus Drill Cover System is a sterilisable and reusable cover that fully encloses a 
hardware drill, transforming it into a surgical grade drill. The Drill Cover System consists of 
a robust, double-layered surgical-grade textile which attaches to a drill’s mechanics via a 
waterproof chuck adapter interface (Figures 1-6). This creates a completely sealed barrier 
between the non-sterile drill on the inside and the sterile surgical field outside. The chuck has 
a lifetime of at least 600 use cycles when reprocessed appropriately. It can be autoclaved up 
to 75 times and will be sterile after 30 minutes exposure of steam autoclave at 121°C, or after 
15 minutes at 131°C, either by using gravity displacement or pre-vacuum autoclaves [10]. 
Arbutus Medical Inc. provides two versions; the S, which is used with a surgical drill to 
increase uptime throughout the day and extend its lifetime by eliminating the harsh 
sterilization cycles that drills must otherwise undergo, and the Hex, which is used with a 
standard hardware drill. (For product suite, please see video supplement 1). It has been 
designed for easy assembly following sterile technique, and the cover material is soft enough 
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for the surgeon to control the drill through the fabric without hindrance. The textile and 
manufacturing techniques follow an AAMI/ANSI PB70 standard for Level 4 medical 
barriers. The Drill Cover is CE marked as a Class I medical device, registered with the US 
FDA and approved with Health Canada. Further tests are being conducted to re-classify the 
whole package of cover plus drill as a CE Class IIa device. 
How does it work? 
The Arbutus Drill Cover System is assembled by inserting a non-sterile hardware drill into a 
sterile cover. The bag edges are rolled down with fingers tucked under during loading, before 
being rolled back and sealed to encase the hardware drill. (For loading and assembly, please 
see video supplement 2). This is a standard process used in other types of surgery to provide a 
sterile barrier, most notably arthroscopic procedures, where a cover is placed over a non-
sterilisable camera and light source. 
Turnaround time between cases can be as quick as 1-minute, by switching out a soiled Drill 
Cover for a sterile one; permitting frontline staff to treat more patients with faster drill turn-
around between cases. The Drill Cover can be used with both inexpensive off-the-shelf 
hardware drills, or with current surgical drills, thereby prolonging their lifespan by reducing 
wear and tear from repeated autoclaving and requiring the purchase of fewer clinical drills. 
Hence, while there is greater potential for cost saving in using the cover along with the 
commercial hardware drill, there are benefits to using the cover alone.   
The benefit in using commercial hardware drills is the significantly lower upfront cost 
investment and the ability to easily replace the drills in the event of breakdown. The company 
recommends the Drill Cover System is paired with a DeWalt DCF610S2; an affordable and 
robust hardware drill carefully selected and tested to closely match the speed, torque, and 
power offered by surgical drills. The DeWalt drill is commercially and widely available in 
hardware stores around the world. User feedback we collected from surgeons suggests that in 
many cases they find the commercial hardware drill, specifically the DeWalt, to be 
ergonomically easy to use, small, compact, light, powerful, and overall better than a lot of old 
generation surgical drills used in the developing world and also many NHS Hospitals.  
The DeWalt drill has been electrically tested to ensure there is no interference with other 
operating room equipment and tests show that the hardware drill battery lasts much longer 
and is cheaper to replace. The recommended DeWalt drill costs as little as £100 vs. £23-30K 
for a contemporary surgical drill, replacement batteries cost as little as £30 vs. £1500, 
respectively. As the DeWalt drill is a critical component of the Arbutus Drill Cover System, 
the company’s regulatory and ISO 14971 Risk Management process takes in to account the 
safety and efficacy of the DeWalt drill when used as part of the system. 
How has the company been funded? 
Arbutus Medical Inc. was established in 2014 as a for-profit medical devices company 
funded by Grand Challenges Canada, a non-profit initiative funded by the Government of 
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Canada – with an initial investment of $1 million. Prior to this the company received support 
from Canada based Coast Capital Savings Innovation Hub, a social venture accelerator 
operated by the UBC Sauder School of Business, and the Lean Launch Pad Accelerator 
program offered by entrepreneurship@UBC [12]. The company has also received funding 
from impact angel investors with a dual focus on financial and health impact returns. These 
include physicians, successful former and current entrepreneurs, family offices/foundations 
(e.g. Threshold Impact, D. Keith MacDonald Foundation), and sophisticated healthcare 
investors (Angel One Network, SWO Angels). 
What is the business model? 
Arbutus Medical Inc. seeks to sustain and expand its offering by earning a profit from the 
sale of the Arbutus Drill Cover System. Presently, Arbutus products are available in 15 
countries, and the company hopes to expand its reach across Africa, Latin America, India, 
Turkey, and the Philippines in the near future. Most recently it has begun to explore markets 
in the US, Canada, South Africa, and the UK, with clinical pilots in the planning stages in 
each country. In the developing world it sells to hospitals through distributors. 
A financial and economic model co-developed in partnership with Imperial College 
Healthcare Partners, a member organisation of the NHS academic health science network, 
and in conjunction with Arbutus Medical Ltd, evaluated initial capital investment based on 
recent and real purchasing data, as well as projected the 5-year costs of supplying the NHS.  
At the national level, for example, if the NHS were to replace all incumbent drills with 
similar offerings, (approx. 5000 at estimated cost of £23K per drill), this could cost £115 
million. However, if all of NHS providers were to move to the Arbutus Drill Cover System 
(estimated cost per drill £1500), it could cost as little as £7.5 million; an upfront saving of 
94% in immediate capital outlay.  
At the hospital level, for example, the total costs to equip and maintain surgical drill 
equipment for two theatres over 5 years would be £324,500 (11 drills at £23K per drill with 
annual battery replacement for years 2-5) while the Arbutus Drill Cover System would be 
£47,993 (2 drills + 2 saws; 22 initial linens; 14 p.a. replacement linens and 4 replacement 
batteries per drill for years 2-5), a saving of 85%. 
What is the operating model? 
Design, engineering and manufacturing are based in Canada while sales and marketing is 
spread globally, primarily in the developing world. Arbutus Medical has 9 full time 
employees and over half a dozen contractors and interns. The company’s key performance 
metrics are both sales and revenues as any typical company, but also the impact that they 
have socially as measured by number of patients treated and disability avoided. The product’s 
key performance metrics are number of cycles possible for delivering safe surgery and cost 
savings in comparison to competitors, as well as the ease of use and integration into existing 
surgical workflows.  
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How is the innovation being spread? 
The development of the Arbutus Drill Cover System has always been grounded in the needs 
of frontline clinicians and patients, with a vision to provide increased access to safer surgery. 
As such they have developed a network of clinical champions, which have helped spread 
knowledge about the innovation and the company vision.  
To date the Drill Cover System has been used to treat 30,000 patients, in 50 hospitals across 
15 LMICs. In all of their global markets, the company relies upon local distributors, with 
support from local staff on the ground. In addition, the company leverages partnerships with 
orthopaedic education and humanitarian organizations like the AO Alliance Foundation to 
create awareness of the product by supporting training activities globally. In order to support 
the most underserved communities Arbutus also works with groups like Medecins Sans 
Frontieres and Canadian Relief for Syria to introduce the Drill Cover System for conflict and 
disaster relief.  
Evidence for use in the HIC markets is currently developing; this includes sales to the 
Canadian military, where feedback from field use has been very positive and plans are 
underway to possibly replace all existing surgical drills with the Arbutus products in the field. 
The company is also hoping to support a pilot use case in the UK, which is being planned by 
the Institute of Global Health Innovation (IGHI) and Imperial College Health Partners 
(ICHP). 
What are future prospects? 
Whilst the innovation was initially conceived and developed for the needs of LMICs, it also 
provides an opportunity for hospitals in HIC to save money whilst still meeting institutional 
requirements. Given the financial pressures on healthcare providers in HICs, and the 
significant cost-saving potential, this may represent a more stable market for growth. 
Future product improvements include an oscillating saw, cannulated drill and reamer 
functionality, and a quick coupling mechanism for numerous attachments. These incremental 
enhancements have been made to align closer with current surgical drill offerings in HICs. 
The company hope to launch the saw at the end of 2017 and the cannulated drill & reamer at 
the beginning of 2018.  
What were / are the big challenges to making this successful?  
Initially, the main challenge was in achieving regulatory approval, however, these hurdles 
have now mostly been overcome through investment in design, engineering and testing of 
products by third party evaluators. Beyond product development, for small start-ups like 
Arbutus, global marketing, securing distribution networks, and navigating procurement 
processes are some of the big challenges they face. Presently, the company is exploring the 
best sales strategy for increasing market share in LMICs. Procurement processes can be 
complex and opaque; as Arbutus Medical Inc. is restricted to sales through locally registered 
distributors in some contexts. Unfortunately, these distributors are more interested in selling 
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‘big-ticket’ items, where sales effort is less and margins can be greater, as compared with the 
necessary repeated sales of a low-cost item; such as the Arbutus Drill Cover System. Indeed, 
communication between distributors and hospitals can be poor, and evidence was found of 
bags being used beyond their lifespan, a potential patient safety risk, which is contrary to, and 
threatens Arbutus’s vision of increasing access to safer surgery. Furthermore, distributors are 
also not always interested in selling to the Tier 2 & 3 hospitals, where poorer patients are 
treated, and which Arbutus wants to reach, and so alignment of vision between the right 
distributor and the company is key.  
In LMICs, Arbutus Medical Inc. faces intense competition from multiple other drilling 
solutions, these include hand drills, homemade but unsafe imitation drill covers, low-cost 
Chinese manufactured surgical drills, and donated Western surgical drills. In all hospitals 
visited evidence was found of offerings being used simultaneously and interchangeably. 
Proving cost-effectiveness versus low-cost Chinese manufactured drills is proving 
challenging, especially where quality standards for manufacturing processes and longer-term 
cost-savings are lower down the list of procurement prerequisites. Furthermore, once Arbutus 
becomes more widely known, it would not be surprising to see use of replicas in unprotected 
developing markets. To further compound the challenges, most recently incumbent 
manufacturers, such as Stryker, have begun to offer specific solutions for LMIC markets, 
though these offer a reduction of only about 30-50% compared to western offerings, while 
Arbutus product can offer up to a 94% reduction. 
How were major challenges overcome? 
Arbutus is working closely with distributors like Crown Healthcare Africa and leading global 
orthopaedics education organization AO Alliance Foundation to develop the best model for 
scaling. In India, the company founders are working with a range of organizations to develop 
market access strategies, including Intellecap and Sanrai International. The Arbutus team are 
supported through mentorship by a number of industry experts such as the senior 
management team of Edmonton-based medical device company priMED Medical Products, 
and the former Africa Director for Johnson & Johnson surgical sales who sits on the Arbutus 
Board.  
There is also still need to address demand for economic evidence of cost saving especially 
against Chinese drills. One option could be to offer a subscription model with unlimited 
number of Drill Covers for a set monthly fee. A Chinese drill may last anywhere from 1-3 
years based on quality and may cost as little as $1500 (£1200); a subscription model would 
need to compete both in cost and lifespan. However, such a model could avoid the danger of 
bags being over-used beyond the recommended number of cycles, resulting in patient safety 
and brand risk. 
How is impact evaluated?  
Impact is projected based upon estimated number of surgeries performed with the Arbutus 
Drill Cover System from client hospital facilities. At specific sites the company is trying to 
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measure more complex clinical and socioeconomic indicators; work is on-going. Laboratory 
tests have examined drilling time; drilling accuracy; plunge depth, weight & size; drill speed 
and torque. Reputable external laboratories have undertaken in-depth electrical safety and 
hydrostatic pressure testing for barrier performance, as well as comprehensive cleaning and 
sterilization validation. A full list of tests is shown in table 1. 
Currently, limited data is available on clinical outcomes as compared to alternative drilling 
methods; however there have been no reported adverse events over the course of more than 
30,000 cases performed with the Drill Cover System. Nevertheless, the Drill Cover System 
meets all required standards for use in the UK, and clinical outcome data is only needed as 
part of a post-market analysis. 
DISCUSSION 
Does the UK need this innovation? With the NHS under pressure to save £22 billion by 2020, 
any little or significant cost savings can contribute towards that goal. We have explored this 
one specific frugal innovation to evaluate prospects savings it affords. At £10 billion, 
musculoskeletal disease has the third largest budget and already accounts for over 25% of 
surgical interventions within the NHS [4]. The Arbutus Drill Cover System presents a viable, 
regulatory approved alternative, which is much cheaper than mainstream commercial 
offerings generally considered in procurement. The UK is estimated to have 5,000 surgical 
drills that each cost around £23,000, which is a major and critical component needed in 
orthopaedic surgeries. The Arbutus Drill Cover System costs around £1500. As shown above, 
depending on whether a comparative assessment is done for one hospital or for all of the 
NHS, and whether it is done for upfront costs or total costs incurred for a period of five years, 
potential savings range from 85% to 94%. 
According to anecdotal evidence from surgeons working in the NHS, some of the drills 
currently being used are not fulfilling their expectations. Drills are often out-dated and will 
soon need replacement. The more likely and only current option is to procure exorbitantly 
expensive clinical drills. Incumbent offerings involve autoclaving the whole drill along with 
the battery, a long established practice and one that is only now beginning to be challenged 
out of necessity of unaffordability in low income settings and increasing pressures for savings 
in high income settings. The alternative practice of only autoclaving the cover could deliver a 
cost reduction. And quality of care would be unchanged but at a fraction of the cost. 
Hospitals are typically equipped with many contemporary and expensive drills because turn-
around time can be long for sterilization of equipment, which is typically done offsite. The 
Arbutus system requires fewer drills, whether surgical or hardware ones, as only the cover 
needs to be swapped and sent off for sterilization after each surgery. Given there are many 
expensive drills already in use, to make the transition smoother from the old to the new, the 
lifespan of existing surgical drills can be prolonged as fewer are needed and the drill and 
battery itself does not need to be sterilized after each surgery. 
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Evidence of use in the Western markets is currently developing; this will make it easier to sell 
the device in the UK, Canada and US. This includes sales to the Canadian military, where 
feedback has been very positive and plans are underway to possibly replace all existing 
surgical drills with the Arbutus products in the field. As well, Arbutus is currently launching 
a pilot at the 4 largest teaching hospitals in Johannesburg, South Africa, with clinical 
champions bought in. Similar pilots are being planned in Canada and the US. Finally, the 
company is also supportive of facilitating a pilot use case in the NHS, which is being planned 
by the Institute of Global Health Innovation (IGHI) and Imperial College Health Partners 
(ICHP). 
IGHI and ICHP are working closely with Arbutus to build the use and business case for NHS 
to consider adopting this innovation through a pilot study at major London hospitals. Arbutus 
is supportive of this pilot and is ready to back its product offering with warranty and 
replacement guarantees. Drills are covered by a 2-year manufacturer’s warranty. Arbutus 
Drill Cover Linens are covered for 75 cycles given normal use conditions. Arbutus Drill 
Cover Chucks and Adapters are covered by a 1-year Arbutus warranty. As a positive show of 
confidence and support, and to help de-risk the initial use case, the company is willing to 
consider a partial refund, rebate, or free replacements if  actual use case scenario significantly 
differs from the predicted model.  
The technology offering as an innovation cannot be considered without carrying out due 
diligence on the type of organisation backing it, its capacity to scale up, and meet the 
requirements of large health systems. The company is backed by impact investors and 
venture capital funds like Grand Challenges Canada. The company is run by a team of 
dedicated bioengineers and social entrepreneurs, who are supported by reputable mentors. 
The company has partnered with the AO Alliance Foundation, one of the leading orthopaedic 
education institutions and has secured professional champions in several frontline and major 
public, private, and NGO-based hospitals who are using it and providing crucial user 
feedback for further development of the offering. However most of these are frontline 
surgeons (see for instance article in the Guardian [13]), and while they are important to 
secure buy-in for use in the theatre, Arbutus probably needs to extend its list of innovation 
champions to procurement decision-makers.  
The innovation journey from bench to bedside is fraught with challenges and risks. Some 
potential challenges to wide scale adoption that need to be considered by any organisation 
seeking to pilot this for use in high income countries include: 
1. In LMICs, incumbent companies are already giving away reconditioned drills in 
target market areas of the Arbutus drill. They are also coming up with less costly 
alternative models (e.g. Stryker System G). Low cost Chinese competitors are also 
available and range from $800 to $3,000, but vary significantly in quality.  
2. In the NHS, behavioural reticence and cognitive bias could render uptake of Arbutus 
Drill Cover a slow process [14,15].	But these can be overcome with client education 
and evidence of safety and efficacy as well as through directives from management in 
favour of cost efficiency savings.  
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3. As the Drill Cover needs to be replaced after 75 cycles, NHS procurement decision 
makers need to be convinced of overall system wide cost savings beyond just the 
initial capital outlay. This system analysis is underway between IGHI, ICHP, Arbutus 
and pilot test sites. 
4. While the parties involved in this study have attempted to carry out preliminary due 
diligence on the supplier in so far as proposing and planning pilot use cases, the full 
due diligence activity for wide scale adoption is best carried out by the procurement 
departments negotiating the full deal.  
 
We have presented here the prospects of potentially significant cost savings from one specific 
frugal innovation. At the same time we caution against relying too much on one product for 
wide scale savings across a large health system. But our argument here is that such 
consideration for testing and implementation needs to be taken piece meal, step-by-step, and 
meticulously through small but several pilot tests. Such efforts when taken together, can offer 
significant savings across the system. And this is only possible if we embrace cultural change 
and create openness among health systems to innovations from unusual sources and that 
involve unorthodox practices which challenge long held practices. 
 
CONCLUSIONS 
As a frugal innovation, the Arbutus Drill Cover medical device holds much promise in 
reducing upfront and lifespan costs for one of the most fundamental equipment to the practice 
of orthopaedic surgery without any loss of effectiveness or safety benchmarks. The 
innovation has gone through rigorous internal and third party evaluations for medical devices. 
However, if the NHS is to realise the significant cost-saving potential of Arbutus Drill Cover 
System, the innovation will need support to navigate the complicated and decentralized 
procurement processes of such a large health system, and clinicians and healthcare leaders 
will need to overcome cognitive bias against an innovation deemed to be untraditional. 
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SUPPLEMENTARY DATA (Videos, Figures, Tables) 
 
Video File 1: Arbutus Medical Product Portfolio 
Video File 2: DrillCover System Loading Instructions 
 
Figure 1: Arbutus Medical Drill Cover fully sealed with DeWalt drill beside.  
Figure 2: Arbutus Medical Drill Cover System disconnected to show chuck mechanism 
and linen, with DeWalt drill beside. 
Figure 3: Drill Cover System being assembled.  
Figure 4: Close-up of the Drill Cover System, specifically highlighting fully sealed 
waterproof chuck interface. 
Figure 5: Oscillating saw launching towards the end of 2017. Product will feature a 
quick-change cam mechanism for easily switching blades (not shown here)  
Figure 6: Cannulated drill and reamer launching early 2018. This features a universal 
quick-change interface for easy exchange of AO, Jacobs, Hudson, and K-wire collet 
during practice. 
 
 
Table 1: Evaluations completed on the product 
 
1. Hydrostatic Pressure 
Testing for Barrier 
Performance:  
Barrier performance evaluation for all critical zones 
within metal and linen components of product, using 
pressurized testing with simulated blood. 
2. Biological Evaluation Cytotoxicity testing, chemical composition of 
constituent materials, effects of manufacturing 
processes, effects of interaction between materials and 
contact with patient, material degradation and 
leachable substances.  
3. Usability and Human 
Factors Evaluation 
Formal usability and human factors evaluation 
completed with nurses and surgeons to ensure ease of 
use while maintaining sterility, as well as validation 
of labelling and training materials. 
4. Lifetime Testing Extensive lifetime and durability testing in high-
fidelity simulated use environments to ensure linens 
and other components withstand the demands of in-
field use. 
5. Electrical Evaluation Third party lab evaluations with QAI Labs to show 
electromagnetic compatibility, electromagnetic 
interference, and leakage in line with EMI 
requirements for medical devices. 
6. Drill In-field Use and 
Warranty Data 
Analysis of warranty claims from Bosch and DeWalt 
over hundreds of thousands of drill devices in the 
field confirm electrical risk analysis results and 
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safety. 
7. Drill Performance Studies Evaluations to ensure appropriate drill speed, torque, 
pull-out strength, and over-heating performance. 
8. Bone Drilling Performance 
Study 
Evaluation of surgical drill and Arbutus Drill Cover 
System drilling into bone models by surgeons showed 
no statistically significant difference in hole size, 
accuracy, usability, or time. 
9. Steam Sterilization and 
Cleaning Validation 
External lab testing with Nelson Laboratories to 
confirm and validate effectiveness of steam 
sterilization protocol and instructions. 
10. Clinical Study Clinical evaluation focused on usability showed 
preference over manual hand drills across 95 
orthopaedic cases, showing a 30 minute reduction 
time per case over manual drills. 
11. Packaging Performance 
Evaluation 
Verifies packaging performance for safety of shipping 
and storage. 
12. ISO 13485 Certified Quality 
Management System 
All Arbutus products are designed, manufactured, 
stored, and marketed under a carefully controlled ISO 
13485 QMS as certified by BSI. 
13. Comprehensive ISO 14971 
Risk Management File 
Arbutus Medical follows a rigorous ISO 14971 Risk 
Management process for ensuring safety and efficacy 
of all products. 
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